Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss

Medicines in development in 2009 for liver cancers

0 views
Skip to first unread message

SciMedWeb

unread,
Dec 19, 2009, 5:46:28 AM12/19/09
to
Medicines in development in 2009 for liver cancers:

● ABT-869 Phase II
● amsilarotene Phase I/II
● Armala (pazopanib) Phase I
● ARQ-197 Phase I
● Avastin (bevacizumab) Phase II
● AZD6244 Phase II
● batabulin Phase III
● belinostat Phase I/II
● brivanib (VEGFR/FGFR kinase inhibitor) Phase III
● CRS-100 Phase I
● darinaparsin (ZIO-101) Phase II
● DENSPM Phase I/II
● doxorubicin (percutaneous hepatic perfusion)
● EHC-18 Phase I
● eniluracil Phase I/II
● ferucarbotran
● GC-33 Phase I
● IMC-1121B Phase II
● IMC-A12 Phase II
● JX-594 Phase II
● mapatumumab Phase I/II
● MB-7133 Phase I/II
● melphalan drug delivery system Phase III
● NV1020 Phase I/II
● patupilone (EPO906) Phase II
● Photofrin (porfimer sodium) Phase II
● PR-104 Phase I
● SCH-58500 (p53 gene therapy) Phase I
● Sutent (sunitinib) Phase III
● tacatuzumab-Y-90 (IMMU-105) Phase I
● Tarceva (erlotinib) Phase II
● Thermodox (LTSDEL) Phase III
● Thymitaq (nolatrexed) Phase III
● TJ9 Phase II


InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scim...@mail.com)


0 new messages